Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4288822
Max Phase: Preclinical
Molecular Formula: C39H56F3N7O9
Molecular Weight: 709.89
Molecule Type: Small molecule
Associated Items:
ID: ALA4288822
Max Phase: Preclinical
Molecular Formula: C39H56F3N7O9
Molecular Weight: 709.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCONC(=N)N)NC(=O)OCc1ccccc1)C1CCCCC1)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C37H55N7O7.C2HF3O2/c1-25(2)22-30(31(45)23-32(46)40-20-18-26-12-6-3-7-13-26)41-35(48)33(28-16-10-5-11-17-28)43-34(47)29(19-21-51-44-36(38)39)42-37(49)50-24-27-14-8-4-9-15-27;3-2(4,5)1(6)7/h3-4,6-9,12-15,25,28-31,33,45H,5,10-11,16-24H2,1-2H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)(H4,38,39,44);(H,6,7)/t29-,30-,31-,33-;/m0./s1
Standard InChI Key: ARTIPZVRVOALHG-ORIXBOIQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 709.89 | Molecular Weight (Monoisotopic): 709.4163 | AlogP: 2.79 | #Rotatable Bonds: 20 |
Polar Surface Area: 216.99 | Molecular Species: BASE | HBA: 8 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.38 | CX Basic pKa: 9.86 | CX LogP: 3.14 | CX LogD: 1.00 |
Aromatic Rings: 2 | Heavy Atoms: 51 | QED Weighted: 0.04 | Np Likeness Score: 0.19 |
1. Nguyen W, Hodder AN, de Lezongard RB, Czabotar PE, Jarman KE, O'Neill MT, Thompson JK, Jousset Sabroux H, Cowman AF, Boddey JA, Sleebs BE.. (2018) Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2 position of PEXEL peptidomimetics., 154 [PMID:29800827] [10.1016/j.ejmech.2018.05.022] |
Source(1):